We are live on ! Find out more
GTBP icon

GT Biopharma
GTBP

20 hedge funds and large institutions have $3.98M invested in GT Biopharma in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.09% more ownership

Funds ownership: 0% → 0.09% (+0.09%)

Holders
20
Holders Change
+20
Holders Change %
–
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.56M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$759K
3
Northern Trust
Northern Trust
Illinois
+$200K
4
Millennium Management
Millennium Management
New York
+$162K
5
IEFM
IQ EQ Fund Management
Ireland
+$153K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.83M +$1.56M +8,922 New
Geode Capital Management
2
Geode Capital Management
Massachusetts
$891K +$759K +4,346 New
Northern Trust
3
Northern Trust
Illinois
$235K +$200K +1,146 New
Millennium Management
4
Millennium Management
New York
$191K +$162K +930 New
IEFM
5
IQ EQ Fund Management
Ireland
$180K +$153K +877 New
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$167K +$143K +818 New
VF
7
Virtu Financial
New York
$156K +$132K +758 New
CCM
8
Conway Capital Management
California
$130K +$111K +633 New
Squarepoint
9
Squarepoint
New York
$113K +$96.3K +551 New
UBS Group
10
UBS Group
Switzerland
$27K +$22.9K +131 New
Morgan Stanley
11
Morgan Stanley
New York
$18K +$15.2K +87 New
Rockefeller Capital Management
12
Rockefeller Capital Management
New York
$13K +$11.7K +67 New
Osaic Holdings
13
Osaic Holdings
Arizona
$10K +$8.21K +47 New
TRCT
14
Tower Research Capital (TRC)
New York
$9K +$7.86K +45 New
TF
15
TimeScale Financial
Massachusetts
$4K +$3.15K +18 New
Wells Fargo
16
Wells Fargo
California
$1K +$699 +4 New
SPIA
17
Steward Partners Investment Advisory
New York
$198 +$175 +1 New
APA
18
American Portfolios Advisors
New York
$96 – – –
HI
19
Harbour Investments
Wisconsin
– +$175 +1 New
RG
20
Retirement Group
California
– +$175 +1 New
TCM
21
Tradewinds Capital Management
Washington
– +$175 +1 New

GTBP Hedge Fund Activity: Q1 2021 in Review

20 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in GT Biopharma (GTBP) for Q1 2021, worth a combined $3.98M.

Buyers outnumbered sellers: 20 funds opened new GTBP positions and 0 closed out — a net gain of 20 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $1.56M.

  • 20 institutional investors held GT Biopharma (GTBP) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $3.98M of GT Biopharma stock for Q1 2021.
  • 20 funds opened new GT Biopharma positions in Q1 2021 and 0 closed out, a net change of +20 holders.
  • The largest GT Biopharma buyer in Q1 2021 was Vanguard Group, an estimated $1.56M added.

Based on aggregated 13F filings for Q1 2021.